Q:   ENDOVASC  LTD.,  INC.  JUST  COMPLETED  A  REINCORPORATION  FROM  NEVADA TO
     DELAWARE.  WHY  IS  ENDOVASC  LTD.,  INC.  REINCORPORATING  BACK TO NEVADA?

A:   Unfortunately,  the  reincorporation  in Delaware did not accomplish all of
     our  goals  regarding  identification  of our stockholders. We believe that
     there  are  a  substantial number of our shares that have been sold "short"
     without  the delivery of certificates representing the shares sold. This is
     known  as  a  "naked  short"  and,  we believe, has resulted in significant
     downward  pressure  on the value of our common stock. Nevada law permits us
     to  require the delivery of certificates representing our shares when there
     is  a  change  in  our capital structure and, thereby, reduce the number of
     "naked  short"  positions  affecting  the  price  of  our  common  stock.

     In  addition,  we  have recently filed significant litigation alleging that
     certain  individuals  engaged  in  manipulation  of  our stock prices. As a
     Delaware  corporation,  we  may  be  subject  to  protracted  litigation in
     Delaware.  The  judicial system and courts in Nevada are significantly less
     expensive  and  more  responsive  to  the  needs  of  corporations that are
     involved  in  litigation.

     Finally,  Nevada  imposes  no  income  taxes  or  franchise taxes on Nevada
     corporations.  We  believe  that  we  will  be able to save tax expenses in
     Nevada  when  we  obtain  profitable  operation.

Q:   WHY  ISN'T ENDOVASC LTD., INC. HOLDING A MEETING OF STOCKHOLDERS TO APPROVE
     THE  REINCORPORATION?

A:   The  board  of  directors has already approved the reincorporation plan and
     has  received  the  written  consent of officers, directors, and affiliates
     that  represent  a  majority  of our outstanding shares of common stock and
     other  voting  interests.  Under  Delaware  General Corporation Law and our
     Certificate  of  Incorporation  this  transaction  may  be  approved by the
     written  consent  of a majority of the shares entitled to vote on it. Since
     we have already received written consents representing the necessary number
     of  shares,  a  meeting  is  not necessary and represents a substantial and
     avoidable  expense.

Q:   WHAT ARE THE PRINCIPAL FEATURES OF THE REINCORPORATION?

A:   The reincorporation will be accomplished by a merger of ENDOVASC LTD., INC.
     with and into our wholly owned subsidiary, ENDOVASC, INC. One and one-fifth
     fully  paid  and  non-assessable share of ENDOVASC, INC. will be issued for
     each  outstanding  share  of  our  common  stock  that  is  held  by  our
     stockholders.  In  addition,  one  fully  paid  and non-assessable share of
     ENDOVASC,  INC.  will  be  issued  for  any  fractional share that would be
     issuable  as  a result of the reincorporation. The shares of ENDOVASC LTD.,
     INC.  will cease to trade on the over-the-counter bulletin board market and
     the shares of ENDOVASC, INC. will begin trading in their place beginning on
     April 1, 2003, under a new trading symbol and CUSIP Number that has not yet
     been  assigned.  Other securities of ENDOVASC LTD., INC., such as preferred
     stock,  options,  warrants,  other  rights  to  purchase  common stock, and
     securities  exchangeable for or convertible into our common stock will also
     be  exchanged  for  similar  securities  issued  by  ENDOVASC,  INC.

Q:   HOW  WILL  THE  REINCORPORATION  AFFECT THE OWNERS, OFFICERS, DIRECTORS AND
     EMPLOYEES  OF  ENDOVASC  LTD.,  INC.?

A:   After  the  effective  date of the reincorporation and the exchange of your
     stock  certificates, you will own the same class and the same percentage of
     ENDOVASC,  INC.,  subject only to insignificant differences relating to the
     elimination  of  fractional  shares.  Our officers, directors and employees
     will  become  the officers, directors and employees of ENDOVASC, INC. after
     the effective date of the reincorporation. ENDOVASC, INC. will continue our
     business  at  the  same  locations  and  with  the  same  assets.

Q:   HOW  DO  I EXCHANGE CERTIFICATES OF ENDOVASC LTD., INC. FOR CERTIFICATES OF
     ENDOVASC,  INC.?

A:   Enclosed  with  this  Information  Statement is a letter of transmittal and
     instructions  for surrendering certificates representing our shares. If you
     are a record stockholder, you should complete the letter of transmittal and
     send  it with certificates representing our shares to the address set forth
     in the letter. Upon surrender of a certificate for cancellation with a duly
     executed letter of transmittal, ENDOVASC, INC. will issue a new certificate
     representing  the  number  of  whole  shares  of  ENDOVASC, INC. as soon as
     practical  after the effective date of the reincorporation. If you hold our
     stock in street name or in a brokerage account, we encourage you to request
     that  certificate  be  issued  to  you  so  that  you can exchange it for a
     certificate  representing  shares  of  ENDOVASC,  INC.

Q:   WHAT HAPPENS IF I DO NOT SURRENDER MY CERTIFICATES OF ENDOVASC LTD., INC.?

A:   YOU  ARE REQUIRED TO SURRENDER CERTIFICATES REPRESENTING SHARES OF ENDOVASC
     LTD., INC. TO RECEIVE SHARES OF ENDOVASC, INC. All shares of Endovasc Ltd.,
     Inc.  outstanding  after  the effective date of the reincorporation will be
     cancelled.  Until you receive shares of ENDOVASC, INC. you are not entitled
     to  receive  notice of or vote at stockholder meetings or receive dividends
     or  other  distributions  on the shares of ENDOVASC, INC. Under the General
     Corporation Law of the State of Nevada, we may seek to enforce the delivery
     of  certificates  for  exchange  through  proceedings  in  court.